PTC Therapeutics, Inc. (PTCT) stock analysis

In our weekly check, PTC Therapeutics, Inc. is graded C (A to F). Of 22 checks on debt, profit, cash flow and trend: 12 pass, warnings: 3, red flags: 7.

About PTC Therapeutics, Inc.

PTC Therapeutics, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as PTCT.

What our checks show for PTCT

Red flags

Warning signs

Strengths

Similar companies

SRRK · DNTH · MANE · ERAS · COGT · EWTX

Questions

What grade does PTC Therapeutics, Inc. (PTCT) have?

In our weekly check, PTC Therapeutics, Inc. is graded C (A to F). Of 22 checks on debt, profit, cash flow and trend: 12 pass, warnings: 3, red flags: 7. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of PTCT stock?

This week's biggest flags for PTC Therapeutics, Inc.: Weak interest cover, Weak EPS growth, Thin margins. In total 10 of 22 checks show a warning or a red flag.

What does PTC Therapeutics, Inc. do?

PTC Therapeutics, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as PTCT.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis